FDA Adds Rare Eye-Risk Warning to GLP-1 Medicines
The FDA is requiring warning-label updates for GLP-1 drugs after reviewing data on a rare eye condition that can cause sudden, permanent vision loss.
Tag: tirzepatide
The FDA is requiring warning-label updates for GLP-1 drugs after reviewing data on a rare eye condition that can cause sudden, permanent vision loss.